SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-139069
Filing Date
2022-05-04
Accepted
2022-05-03 20:34:09
Documents
21
Period of Report
2022-05-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d333422d8k.htm   iXBRL 8-K 34039
2 EX-1.1 d333422dex11.htm EX-1.1 228561
3 EX-5.1 d333422dex51.htm EX-5.1 8580
4 EX-99.1 d333422dex991.htm EX-99.1 9294
5 EX-99.2 d333422dex992.htm EX-99.2 9727
9 GRAPHIC g333422dsp01.jpg GRAPHIC 4521
10 GRAPHIC g333422g0503112426920.jpg GRAPHIC 3894
11 GRAPHIC g333422g0503112427170.jpg GRAPHIC 2504
12 GRAPHIC g333422g0503171336727.jpg GRAPHIC 3915
13 GRAPHIC g333422g0503171402348.jpg GRAPHIC 3915
  Complete submission text file 0001193125-22-139069.txt   514811

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tars-20220502.xsd EX-101.SCH 2847
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tars-20220502_lab.xml EX-101.LAB 18737
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tars-20220502_pre.xml EX-101.PRE 11701
15 EXTRACTED XBRL INSTANCE DOCUMENT d333422d8k_htm.xml XML 3477
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Filer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39614 | Film No.: 22889477
SIC: 2836 Biological Products, (No Diagnostic Substances)